The arrival of an action potential at the presynaptic nerve terminal elicits membrane depolarization and an increase in free Ca2+ concentration. These events trigger the release of neurotransmitters from synaptic vesicles by exocytosis, followed by retrieval of fused synaptic vesicle membranes by endocytosis. This recycling of vesicle membranes is critical for the release process and its impairment is likely to result in paralysis and mental disorders. At present only one enzyme, the GTPase dynamin I, has been shown unambiguously to have an essential function in synaptic membrane retrieval. If the GTPase activity of dynamin I is inhibited, either by mutation or through the use of non-hydrolyzable GTP analogs, deeply invaginated clathrin-coated vesicles remain attached to the neuronal plasma membrane, apparently frozen at a late stage of endocytosis just prior to internalization. The goal of this proposal is to determine how dynamin I activity and, by extension, presynaptic vesicle recycling, is regulated in cells. In particular, two modes of regulation will be explored: stimulus-dependent phosphorylation and dephosphorylation and interaction with specific phosphoinositides. Dynamin I is the major neuronal protein to undergo dephosphorylation upon synaptic depolarization. This project will identify regulatory sites in the dynamin primary structure, assay their importance for the functional properties of the protein in vitro and determine the in vivo significance of these types of regulation by mutating the corresponding amino acids in mice by homologous recombination. The working hypothesis is that the phosphorylation state of dynamin I determines its affinity for protein and/or lipid targets at the clathria-coated put, whereas GTPase activity is controlled by phosphoinositide binding. The phospholipid-interaction sites will be mapped by analysis of site-directed mutants of dynamin I. The structural and kinetic basis of GTPase stimulation by phosphoinositides will be examined. And, as above, the in vivo significance of phosphoinositide binding will be determined by homologous recombination techniques in mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM055562-01A2
Application #
2694674
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1998-08-01
Project End
2002-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Shelton, Shary N; Barylko, Barbara; Binns, Derk D et al. (2003) Saccharomyces cerevisiae contains a Type II phosphoinositide 4-kinase. Biochem J 371:533-40
Wang, Ying Jie; Wang, Jing; Sun, Hui Qiao et al. (2003) Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell 114:299-310
Schafer, Dorothy A; Weed, Scott A; Binns, Derk et al. (2002) Dynamin2 and cortactin regulate actin assembly and filament organization. Curr Biol 12:1852-7
Fernandez-Chacon, R; Achiriloaie, M; Janz, R et al. (2000) SCAMP1 function in endocytosis. J Biol Chem 275:12752-6